Deutsch English Français

Contact

EP1536793

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1536793

EP1536793 - PHARMACEUTICAL COMPOSITIONS COMPRISING FK506 DERIVATIVES AND THE IR USE FOR THE TREATMENT OF ALLERGIC DISEASES [Right-click to bookmark this link]
Status	The application has been withdrawn Status updated on 30.12.2005 Database last updated on 13.09.2024
Most recent event Tooltip	30.12.2005	Withdrawal of application	published on 15.02.2006 [2006/07]
Applicant(s)	For all designated states Sucampo Pharmaceuticals, Inc. 4733 Bethesda Avenue, Suite 450 Bethesda, MD 20814 / US
	[2005/23]
Inventor(s)	01 / UENO, Ryuji 11025 Stanmore Drive, Potomac Montgomery, MD 20854 / US
	[2005/23]
Representative(s)	Gille Hrabal Partnerschaftsgesellschaft mbB Patentanwälte Brucknerstraße 20 40593 Düsseldorf / DE
	[N/P]
Former [2005/23]	Gille Hrabal Struck Neidlein Prop Roos Patentanwälte Brucknerstrasse 20 40593 Düsseldorf / DE
Application number, filing date	03784593.0	08.08.2003
	[2005/23]
	WO2003JP10105
Priority number, date	US20020402061P	09.08.2002 Original published format: US 402061 P
	[2005/23]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2004014373
	Date:	19.02.2004
	Language:	EN
	[2004/08]
	Type:	A1 Application with search report
	No.:	EP1536793
	Date:	08.06.2005
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 19.02.2004 takes the place of the publication of the European patent application.
	[2005/23]
Search report(s)	International search report - published on:	EP	19.02.2004
Classification	IPC:	A61K31/436, A61P27/02	[2005/23]
	CPC:	A61K31/4745 (EP,US); A61K31/436 (EP,KR,US); A61K9/0048 (EP,US); A61P27/02 (EP); A61P27/14 (EP); A61P37/06 (EP); (+) A61P37/08 (EP) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/23]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
Title	German:	OPHTHALMISCHE ZUSAMMENSETZUNGEN ENTHALTEND DERIVATIVE VON FK506 UND DEREN VERWENDUNG IN DER BEHANDLUNG VON AUGENALLERGIEN	[2005/23]
	English:	PHARMACEUTICAL COMPOSITIONS COMPRISING FK506 DERIVATIVES AND THE IR USE FOR THE TREATMENT OF ALLERGIC DISEASES	[2005/23]
	French:	COMPOSITIONS PHARMACEUTIQUES COMPRENANT DES DERIVES DE FK506, ET LEUR UTILISATION POUR LE TRAITEMENT D'AFFECTIONS ALLERGIQUES	[2005/23]
Entry into regional phase	28.02.2005	National basic fee paid
	28.02.2005	Designation fee(s) paid
	28.02.2005	Examination fee paid
Examination procedure	25.02.2004	Request for preliminary examination filed International Preliminary Examining Authority: EP
	28.02.2005	Amendment by applicant (claims and/or description)
	28.02.2005	Examination requested [2005/23]
	19.12.2005	Application withdrawn by applicant [2006/07]
Fees paid	Renewal fee
	19.08.2005	Renewal fee patent year 03
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[X]EP0406791 (FUJISAWA PHARMACEUTICAL CO [JP]) [X] 12,13,16,17,20-22 * page 6, line 51 * * claims 1-3 *;
		[X]EP0484936 (FUJISAWA PHARMACEUTICAL CO [JP]) [X] 12,13,16,17,20-22 * page 6, lines 28,29 * * Prescription 4-6;; claims 1,4 *;
		[X]WO9219278 (UNIV KURUME [JP]) [X] 1-34 * page 1, lines 9-11 * * claims 1,2,5,8 * * page 2, lines 1-4 * * page 8, lines 1-15 * * page 11, lines 1,2 * * examples 1,2 *;
		[X]WO0066122 (R TECH UENO LTD [JP], et al) [X] 1-34 * page 1, lines 15,16 * * example 1 *;
		[PX]WO02085359 (SUCAMPO AG [CH], et al) [PX] 12,13,16,17,20-23 * page 15, lines 10-13 * * page 16, lines 16-19 * * page 18, lines 14-21 * * example -; claims 1,2,4,14; table - *;
		[PX]WO03043650 (SUCAMPO AG [CH], et al) [PX] 1-34 * claims 1,4,6,12,15,17,18,31,33,34; table 1 *;
		[A] - "FUJISAWA Protopic (tacrolimus) FOR DERMATOLOGIC USE ONLY NOT FOR OPHTHALMIC use", INTERNET, (200012), URL: http://www.protopic.com/img/protopic_pi.pdf, (20030205), XP002230797 [A] 1-34 * the whole document *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p